FDA Approves New Drug to Slow Alzheimer’s Disease Study data shows the drug may slow Alzheimer’s progression by 27% over 18 months.
|
FDA Approves New Drug to Slow Alzheimer’s Disease Study data shows the drug may slow Alzheimer’s progression by 27% over 18 months.
|